
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
📡 We watch Kyverna Therapeutics's careers page
Every 2 hours
how often we check
2
roles posted in the last 30 days
About 47 days
usual time to fill a role
71
roles closed in the last year
Selected: 🆕 Date Added.
🕒 October 23
Regulatory leader overseeing biotech advertising, promotion, medical communications, and product labeling. Guiding FDA/EMA compliance, labeling strategy, and cross-functional commercialization.
🇺🇸 United States – Remote
💵 $180k - $205k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
🔴 Lead
🚔 Compliance
👻 Ghost score 2%
🕒 October 20
Regulatory Affairs Consultant advancing regulatory strategy and submissions for Kyverna Therapeutics’ cell therapies. Supporting clinical development for autoimmune disease treatments.
🇺🇸 United States – Remote
💵 $75 - $85 / hour
💰 $85M Series B on 2022-01
⏳ Contract/Temporary
🟢 Junior
🟡 Mid-level
🚔 Compliance
👻 Ghost score 2%
🕒 October 16
Statistical Programmer Consultant leading SAS programming and CDISC data deliverables. Supporting Kyverna Therapeutics’ clinical-stage autoimmune cell therapy trials and regulatory submissions.
🇺🇸 United States – Remote
💵 $80 - $100 / hour
💰 $85M Series B on 2022-01
⏳ Contract/Temporary
🟠 Senior
🖥 Software Engineer
👻 Ghost score 2%
🕒 October 7
Senior safety leader guiding global pharmacovigilance for Kyverna Therapeutics’ autoimmune cell therapy pipeline. Overseeing signal detection, risk management, regulatory compliance, and clinical safety strategy.
🇺🇸 United States – Remote
💵 $320k - $350k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 2%
🕒 October 7
VP Marketing leading CAR-T commercialization and launch strategy for Kyverna Therapeutics’ autoimmune cell therapies. Building the marketing organization and guiding multi-indication lifecycle expansion.
🇺🇸 United States – Remote
💵 $320k - $350k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🔴 Lead
👔 Vice President
👻 Ghost score 2%
🕒 September 10
Cell therapy account specialist leading treatment-center relationships and strategic plans for Kyverna Therapeutics’ autoimmune disease therapies. Driving patient referrals, treatment readiness, and appropriate adoption.
🇺🇸 United States – Remote
💵 $180k - $200k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
💰 Account Manager
👻 Ghost score 8%
🕒 September 10
Cell therapy account specialist supporting Kyverna Therapeutics’ autoimmune disease treatment launch. Managing complex healthcare accounts, referrals, treatment-center readiness, and adoption across the Central/Mountain territory.
🇺🇸 United States – Remote
💵 $180k - $200k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
💰 Account Manager
👻 Ghost score 8%
🕒 August 11
Executive Director leading medical writing for Kyverna Therapeutics, a biopharmaceutical company developing autoimmune disease cell therapies. Overseeing global regulatory documentation, submission strategy, and Medical Writing organization development.
🇺🇸 United States – Remote
💵 $275k - $300k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 16%